Twist Bioscience (TWST)

• Market cap: $2.91B
• 1 day: -3.59%
• 5 days: 1.82%
• 1 month: 34.4%
• 3 months: 53.33%
• 6 months: 71.81%
• Year to date: 46.56%
• 1 year: -2.39%
• 5 years: -73.55%
• 10 years: 239.07%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Employees: 979